Unichem Laboratories Ltd.

420.35 -0.25 ▼-0.1%

01 December 2023, 04:01:00 PM
Volume: 495

Company Profile

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.unichemlabs.com
Market Cap 2,946.48 Cr.
Enterprise Value(EV) 3,157.90 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) -18.94 Trailing Twelve Months Ending 2023-09
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-09
Industry PE 38.75 Trailing Twelve Months Ending 2023-09
Book Value / Share 342.02 Trailing Twelve Months Ending 2023-09
Price to Book Value 1.22 Calculated using Price: 418.50
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 7.04 Cr. 70,405,751 Shares
FaceValue 2
About Unichem Laboratories Ltd.
Unichem Laboratories, incorporated in 1962, is engaged in manufacturing formulations, pharmaceuticals and active pharmaceutical ingredients (APIs). The company was promoted by the late Amrut Mody, a pioneer in the Indian pharmaceuticals business.

Unichem Laboratories Ltd. Delivery

Delivered Qty
Traded Qty

Unichem Laboratories Ltd. Performance

1 Day
-0.06%
1 Week
+2.09%
1 Month
-4.44%
3 Month
+0.66%
6 Month
+12.74%
1 Year
+2.96%
2 Year
+99.22%
5 Year
+105.85%
10 Year
+121.41%

Unichem Laboratories Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 8.95 11.92 10.77 136.04 -0.90 -2.37 1.37 1.28 -8.04
Return on Capital Employed (%) 9.29 14.97 13.42 162.77 -1.77 -1.49 2.12 1.00 -5.60
Return on Assets (%) 6.55 8.82 7.68 108.06 -0.75 -1.94 1.11 1.03 -6.22

Unichem Laboratories Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 868 954 1,064 2,680 2,620 2,531 2,557 2,618 2,435 2,408
Non Curr. Liab. 74 76 64 46 10 44 49 144 108 103
Curr. Liab. 212 275 393 464 503 567 506 552 640 554
Minority Int.
Equity & Liab. 1,153 1,305 1,521 3,190 3,133 3,142 3,112 3,314 3,183 3,065
Non Curr. Assets 589 673 772 854 1,094 1,455 1,734 1,666 1,591 1,529
Curr. Assets 564 632 748 2,336 2,039 1,686 1,377 1,645 1,588 1,536
Misc. Exp. not W/O
Total Assets 1,153 1,305 1,521 3,190 3,133 3,142 3,112 3,314 3,183 3,065

Unichem Laboratories Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09 Rs. Cr. TTM
Net Sales 1,202 1,333 1,540 1,380 1,188 1,104 1,235 1,270 1,343 1,543
Other Income 21 19 6 3,278 98 91 50 48 39 36
Total Income 1,223 1,352 1,546 4,658 1,287 1,195 1,285 1,317 1,382 1,579
Total Expenditure -1,101 -1,169 -1,358 -1,358 -1,269 -1,155 -1,144 -1,197 -1,389 -1,533
PBIDT 122 183 188 3,300 17 40 141 120 -7 46
Interest -3 -3 -3 -8 -8 -8 -5 -6 -17 -22
Depreciation -41 -39 -44 -51 -67 -82 -84 -91 -113 -119
Taxation -2 -29 -33 -696 34 -12 -17 11 -26 -5
Exceptional Items -4 -39 -34
PAT 75 108 108 2,545 -24 -61 35 33 -202 -133
Minority Interest
Share Associate 0 0 0 0 0 1 0
Other Related Items
Consolidated Net Profit 75 108 109 2,545 -24 -60 34 33 -202 -133
Adjusted EPS 8 12 12 362 -3 -9 5 5 -29 -19

Unichem Laboratories Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 87 78 112 68 -112 -328 20 33 -260 -85
Cash Fr. Inv. 36 -52 -85 -128 1,648 -286 -36 -74 102 203
Cash Fr. Finan. -95 -51 -33 59 -881 -2 -62 -121 191 -81
Net Change 28 -25 -7 0 655 -616 -78 -162 34 36
Cash & Cash Eqvt 52 27 20 11 666 197 232 77 109 184

Unichem Laboratories Ltd. Shareholding Pattern

9 Qtrs 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%)
Promoter 50.93 50.93 50.93 50.93 50.93 50.93 50.93 50.93 70.21
Public 49.07 49.07 49.07 49.07 49.07 49.07 49.07 49.07 29.79
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Unichem Laboratories Ltd. Announcements

Fri, 24 Nov 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of loss of share certificate under Regulation 39(3) of SEBI (Listing Obligations Disclosure Requirement) Regulations 2015.
Thu, 02 Nov 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication
Financial results for the second quarter and six months ended September 30 2023 of the financial year 2023-24 were published in the newspapers on November 2 2023.
Wed, 01 Nov 2023
Board Meeting Outcome for Outcome Of Board Meeting Held On November 1 2023
We would like to inform you that Board of Directors at its Meeting held today i.e. Wednesday November 1 2023 approved the Unaudited Financial Results (Standalone & Consolidated) for the Second and Six months ended September 30 2023 of the financial year 2023-24. Enclosed herewith please find the Unaudited Financial Results (Standalone & Consolidated) for the second quarter and six months ended September 30 2023 of the financial year 2023-24 and the Auditors Reports thereon.

Unichem Laboratories Ltd. Technical Scans

Fri, 01 Dec 2023
High Delivery Percentage High Delivery Percentage
Close Crossing Last Month Close from Above Close Crossing Last Month Close from Above
Opening at High Opening at High
Closing Below Previous Low Closing Below Previous Low
Close Within 52 Week High Zone Close Within 52 Week High Zone

Unichem Laboratories Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 295,418.12 1,231.25 +0.4%
Divi's Laboratories Ltd. 100,674.98 3,792.70 +0.1%
Cipla Ltd. 97,418.94 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. 95,866.76 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. 80,322.42 5,570.00 +0.7%
Mankind Pharma Ltd. 76,800.82 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. 72,809.77 2,151.30 +1.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 34.56 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-09 75.59 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-09 28.21 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 18.83 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 115.16 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 59.91 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 54.58 2,151.30 +1.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 4.94 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-09 7.94 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-09 3.92 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 3.76 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 12.36 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 9.11 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 10.86 2,151.30 +1.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-03 0.02 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,151.30 +1.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-03 12.85 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,151.30 +1.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-03 12.85 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,151.30 +1.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,151.30 +1.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,151.30 +1.1%

Unichem Laboratories Ltd. FAQ's

What is Unichem Lab share price?

Can I buy Unichem Lab shares now?

What is the Market Cap of Unichem Lab?

What are the key metrics to analyse Unichem Lab?

What is the 52 Week High and Low of Unichem Lab?

What is the trend of Unichem Lab share price?